glyburide by abhishek jaguessar
TRANSCRIPT
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 1/23
Glyburide (micronase, glynase, DiaBeta)
shows promise for women withgestational diabetes and pregnantwomen with type 2 diabetes
BY
ABHISHEK JAGUESSAR
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 2/23
• What about women with
type 2 diabetes, who aretaking diabetes pills, orwomen who have hadgestational diabetes in thepast?
• Will they need insulin, orwill diabetes pills be okay to
use during pregnancy?
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 3/23
glyburide
Glyburide is a sulfonylurea drug used to lowerblood sugar levels in people with type 2
diabetes(non-insulin-dependent)
Glyburide appears to lower the blood glucoseacutely by stimulating the release of insulin from
the pancreas, an effect dependent upon
functioning beta cells in the pancreatic isletsglyburide, a type of sulfonylurea drug, does not
pass through the placenta
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 4/23
Pharmacokinetics
• C23H28ClN3O5S glyburide
• Single dose studies with glyburide tabletsin normal subjects demonstrate significantabsorption of glyburide within 1 hour, peak
drug levels at about 4 hours (2-3 hours formicronized glyburide), and low butdetectable levels at 24 hours
• Glyburide• Also indexed as: Diabeta®, Glynase
,Prestab®, Micronase®, Pres Tab®
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 5/23
Sulfonylureas – First-Generation Agents:
• Generic Name: acetohexamide
Brand Name: Dymelor • Generic Name: chloropropamideBrand Name: Diabinese
• Generic Name: tolazamideBrand Name: Tolinase
• Generic Name: tolbutamide
Brand Name: Orinase • Second-Generation Agents:• Generic Name: glimepiride
Brand Name: Amaryl • Generic Name: glipizide
Brand Names: Glucotrol ,Glucotrol XL
• Generic Name: glyburideBrand Names: DiaBeta, Micronase ,Glynase
• Combination Agents:• Generic Name: glyburide plus metformin
Brand Name: GlucoVance
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 6/23
dosage
• There is no fixed dosage regimen for themanagement of diabetes mellitus with glyburideor any other hypoglycemic agent. In addition to
the usual monitoring of urinary glucose, thepatient's blood glucose must also be monitoredperiodically to determine the minimum effectivedose for the patient
• Glyburide may be taken with food to avoidgastrointestinal (GI) upset
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 7/23
• Glyburide is a white, crystalline compound,formulated
• as Micronase tablets of• 1.25, 2.5, and 5 mg strengths for oral
administration.
• The usual starting dose of standard glyburide
tablets is 2.5-5 mg daily• (micronized glyburide tablets: 1.5-3 mg daily),
• administered with breakfast or the first mainmeal. Those patients who may be moresensitive to hypoglycemic drugs should bestarted at 1.25 mg of standard glyburide daily(0.75 mg for micronized glyburide daily).
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 8/23
Maximum Dose
• Standard Glyburide: Daily doses of morethan 20 mg are not recommended.
• Micronized Glyburide: Daily doses of morethan 12 mg are not recommended
• glyburideSU generic Intermediate
acting1.25, 2.5, 5mg5 - 20mg
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 9/23
Dosage Interval
• Standard Glyburide: Once-a-day therapy is usually satisfactory. Some patients,particularly those receiving more than 10 mg
daily, may have a more satisfactory response with twice-a-day dosage .
• Micronized Glyburide: Once-a-day therapy is usually satisfactory. Some patients,
particularly those receiving more than 6 mg daily, may have a more satisfactory response with twice-a-day dosag
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 10/23
CONTRAINDICATIONS
• Glyburide Tablets are Contraindicated inPatients with:
• 1. Known hypersensitivity or allergy to the
drug.• 2. Diabetic ketoacidosis, with or without
coma. This condition should be treated
with insulin.• 3. Type I diabetes mellitus, as sole
therapy.
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 11/23
Pregnancy
• , Effects Teratogenic , Pregnancy Category B • Reproduction studies have been performed in rats and
rabbits at doses up to 500 times the human dose and haverevealed no evidence of impaired fertility or harm to thefetus due to glyburide. There are, however, no adequate
and well-controlled studies in pregnant women. Becauseanimal reproduction studies are not always predictive ofhuman response, this drug should be used duringpregnancy only if clearly needed.
• Effects Nonteratogenic
• :4-10 days Prolonged severe hypoglycemia (has beenreported in neonates born to mothers who were receiving asulfonylurea drug at the time of delivery. This has beenreported more frequently with the use of agents withprolonged half-lives. If glyburide is used during pregnancy, it
should be discontinued at least 2 weeks before the expecteddelivery date.
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 12/23
HOW SUPPLIED
Micronase Tablets are Supplied as Follows • Micronase Tablets 1.25 mg: White, round, scored and imprinted
MICRONASE 1.25.• Micronase Tablets 2.5 mg: Dark pink, round, scored and
imprinted MICRONASE 2.5.• Micronase Tablets 5 mg: Blue, round, scored and imprinted
MICRONASE 5. Storage: Store at controlled room temperature 20-25°C (68-77°F).
Keep container tightly closed. Dispensed in well-closed containerswith safety closures.
Glynase PresTab Tablets are Supplied as Follows
• Glynase PresTab Tablets 1.5 mg: White, ovoid, imprintedGLYNASE 1.5/PT Score PT, contour, scored.• Glynase PresTab Tablets 3mg: Blue, ovoid, imprinted
GLYNASE 3/PT Score Pt, contour, scored.• Glynase PresTab Tablets 6 mg: Yellow, ovoid, imprinted
GLYNASE 6/PT Score PT, contour,
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 13/23
• insulin is considered the drug ofchoice for the treatment of
gestational diabetes; however, it isexpensive and its administration is
inconvenient• "Women with gestational diabetes
mellitus are rarely treated with a
sulfonylurea drug, because ofconcern about teratogenicity and
neonatal hypoglycemia .
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 14/23
• . Gestational diabetes is rarely diagnosedduring the first trimester of pregnancy, the
period when organogenesis and moresevere malformations occur. Therefore itseems unlikely that a pregnant femalewould receive treatment for gestational
diabetes during this time period. Eventhough the results of this study showpromise with regards to the use of second-generation sulfonylureas for the treatmentof gestational diabetes, more studies needto be conducted before these medicationscan be considered safe in pregnancy.
A C i f Gl b id d
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 15/23
A Comparison of Glyburide and Insulin in Women with Gestational
Diabetes Mellitus. • The new sulphonylurea called glyburide
does not cross the placental barrier
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 16/23
published in The New EnglandJournal of Medicine
Volume 343 October 19, 2000Number 16
• Of the 404 womenwith singleton pregnancies andgestational diabetes that required treatmen , 201received glyburide and 203 received human insulin
• between 11 and 33 weeks of gestation
• The mean (± SD) serum glucose concentrationobserved during routine visits to the clinic was 102 ±24mg/dl in the glyburide group and 99 ±22 mg/dl in
the insulin group .
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 17/23
• In addition, 82% of women in the glyburidegroup and 88% of women in the insulin grouphad home blood glucose measurements that fell
into the desired range
• .No significant differences existed between thetwo groups with regards to perinatal outcome .
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 18/23
• The incidence of macrosomia between thegroups was similar; 11% in the glyburidegroup and 10% in the insulin group
• .The cord serum of all infants wasmeasured for the presence of glyburide;
however, the drug was not detected in anyof the infants .
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 19/23
• There were no significant differences betweenthe glyburide and insulin groups in thepercentage of infants who were large forgestational age (12 percent and 13 percent,
respectively) • who had macrosomia, defined as a birth weight
of 4000 g or more (7 percent and 4 percent• ); who had lung complications (8 percent and 6
percent
• ); who had hypoglycemia (9 percent and 6percent
• who were admitted to a neonatal intensive careunit (6 percent and 7 percent
• who had fetal anomalies (2 percent and 2 percent)
• The cord-serum insulin concentrations weresimilar in the two groups)
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 20/23
REFERENCES
• Langer OD, Conway DL, Berkus MD, XenakisEMJ, and Gonzales O. A comparison ofglyburide and insulin in women with gestational
diabetes. N Engl J Med 2000;343:1134-38.• Greene MF. Oral hypoglycemic drugs for
gestational diabetes. N Engl J Med2000;343:1178-79.
• Briggs GK, Freeman RK, Yaffe SJ, editors.Drugs in Pregnancy and Lactation. 5th ed.Baltimore: Williams & Wilkins. 1998
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 21/23
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 22/23
• The percentage of newborns who werelarge for their gestational age was similarin both groups of women. In addition, there
were no statistically significant differencesin the infants' rates of birth defects, lungcomplications or low blood sugar.
8/4/2019 Glyburide by Abhishek Jaguessar
http://slidepdf.com/reader/full/glyburide-by-abhishek-jaguessar 23/23
But• We must still exercise caution in
applying these findings to clinical
practice. Results need to beduplicated and the risk for fetalmalformations with the use of
these agents during pregnancyremains a concern."